Evidence map›Paper›PMID 24459671›Full record

ArticleBioMed research international2013

Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration.

Stella M Matthes, Kerstin Reimers, Insa Janssen, Christina Liebsch, Jeffery D Kocsis, Peter M Vogt, Christine Radtke

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Stella M MatthesDepartment of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, 30659 Hannover, Germany.
Kerstin ReimersDepartment of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, 30659 Hannover, Germany.
Insa JanssenDepartment of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, 30659 Hannover, Germany.
Christina LiebschDepartment of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, 30659 Hannover, Germany.
Jeffery D KocsisDepartment of Neurology and Center for Neuroscience and Regeneration Research, School of Medicine, Yale University, New Haven, CT 06510, USA ; Rehabilitation Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA.
Peter M VogtDepartment of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, 30659 Hannover, Germany.
Christine RadtkeDepartment of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, 30659 Hannover, Germany ; Rehabilitation Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA.
Medizinische Hochschule Hannover · DEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral nerve injury is a common and devastating complication after trauma and can cause irreversible impairment or even complete functional loss of the affected limb. While peripheral nerve repair results in some axonal regeneration and functional recovery, the clinical outcome is not optimal and research continues to optimize functional recovery after nerve repair. Cell transplantation approaches are being used experimentally to enhance regeneration. Intravenous infusion of mesenchymal stromal cells (MSCs) into spinal cord injury and stroke was shown to improve functional outcome. However, the repair potential of intravenously transplanted MSCs in peripheral nerve injury has not been addressed yet. Here we describe the impact of intravenously infused MSCs on functional outcome in a peripheral nerve injury model. Rat sciatic nerves were transected followed, by intravenous MSCs transplantation. Footprint analysis was carried out and 21 days after transplantation, the nerves were removed for histology. Labelled MSCs were found in the sciatic nerve lesion site after intravenous injection and regeneration was improved. Intravenously infused MSCs after acute peripheral nerve target the lesion site and survive within the nerve and the MSC treated group showed greater functional improvement. The results of study suggest that nerve repair with cell transplantation could lead to greater functional outcome.

Indexed as

Mesenchymal Stem Cell TransplantationNerve RegenerationAdministration, IntravenousAnimalsAxonsCell- and Tissue-Based TherapyHumansMesenchymal Stem CellsPeripheral NervesPeripheral Nervous System DiseasesRatsSpinal Cord Injuries

Identifiers

PMID24459671
PMCPMC3888686
OpenAlexW2039177817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.